BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27006378)

  • 1. Early Events in the Molecular Pathogenesis of Lung Cancer.
    Kadara H; Scheet P; Wistuba II; Spira AE
    Cancer Prev Res (Phila); 2016 Jul; 9(7):518-27. PubMed ID: 27006378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early detection of ovarian cancer: tomorrow? A review].
    Chene G; Penault-Llorca F; Robin N; Cayre A; Provencher DM; Dauplat J
    J Gynecol Obstet Biol Reprod (Paris); 2013 Feb; 42(1):5-11. PubMed ID: 23182787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of biomarkers for early detection of lung cancer and chemoprevention.
    Hirsch FR; Merrick DT; Franklin WA
    Eur Respir J; 2002 Jun; 19(6):1151-8. PubMed ID: 12108871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Case for a Pre-Cancer Genome Atlas (PCGA).
    Campbell JD; Mazzilli SA; Reid ME; Dhillon SS; Platero S; Beane J; Spira AE
    Cancer Prev Res (Phila); 2016 Feb; 9(2):119-24. PubMed ID: 26839336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression.
    Beane J; Mazzilli SA; Tassinari AM; Liu G; Zhang X; Liu H; Buncio AD; Dhillon SS; Platero SJ; Lenburg ME; Reid ME; Lam S; Spira AE
    Clin Cancer Res; 2017 Sep; 23(17):5091-5100. PubMed ID: 28533227
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical markers of cancerogenesis in the lung.
    Pankiewicz W; Minarowski L; Niklińska W; Naumnik W; Nikliński J; Chyczewski L
    Folia Histochem Cytobiol; 2007; 45(2):65-74. PubMed ID: 17597018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential biomarkers for the early detection of lung cancer.
    Gruidl ME; Shaw Wright GL
    J Thorac Imaging; 2000 Jan; 15(1):13-20. PubMed ID: 10634657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of lung cancer biomarkers through biosensor technology: A review.
    Roointan A; Ahmad Mir T; Ibrahim Wani S; Mati-Ur-Rehman ; Hussain KK; Ahmed B; Abrahim S; Savardashtaki A; Gandomani G; Gandomani M; Chinnappan R; Akhtar MH
    J Pharm Biomed Anal; 2019 Feb; 164():93-103. PubMed ID: 30366148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications.
    Niklinski J; Niklinska W; Chyczewski L; Becker HD; Pluygers E
    Eur J Cancer Prev; 2001 Jun; 10(3):213-26. PubMed ID: 11432708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment.
    Saab S; Zalzale H; Rahal Z; Khalifeh Y; Sinjab A; Kadara H
    Front Immunol; 2020; 11():159. PubMed ID: 32117295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
    Lantuéjoul S; Salameire D; Salon C; Brambilla E
    Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preinvasive lesions of the bronchus.
    Rivera MP
    Clin Chest Med; 2011 Dec; 32(4):693-702. PubMed ID: 22054880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic approaches to accelerate cancer interception.
    Beane J; Campbell JD; Lel J; Vick J; Spira A
    Lancet Oncol; 2017 Aug; 18(8):e494-e502. PubMed ID: 28759388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Diagnosis and Screening for Lung Cancer.
    Kadara H; Tran LM; Liu B; Vachani A; Li S; Sinjab A; Zhou XJ; Dubinett SM; Krysan K
    Cold Spring Harb Perspect Med; 2021 Sep; 11(9):. PubMed ID: 34001525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions.
    Beane JE; Mazzilli SA; Campbell JD; Duclos G; Krysan K; Moy C; Perdomo C; Schaffer M; Liu G; Zhang S; Liu H; Vick J; Dhillon SS; Platero SJ; Dubinett SM; Stevenson C; Reid ME; Lenburg ME; Spira AE
    Nat Commun; 2019 Apr; 10(1):1856. PubMed ID: 31015447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.
    Crowell RE; Gilliland FD; Temes RT; Harms HJ; Neft RE; Heaphy E; Auckley DH; Crooks LA; Jordan SW; Samet JM; Lechner JF; Belinsky SA
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):631-7. PubMed ID: 8824366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular origins of lung cancer: prospects for personalized prevention and therapy.
    Haura EB; Camidge DR; Reckamp K; Chiappori A; Johnson F; Herbst R; Wong K; Carbone D
    J Thorac Oncol; 2010 Jun; 5(6 Suppl 3):S207-13. PubMed ID: 20502275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer epigenetics and genetics.
    Risch A; Plass C
    Int J Cancer; 2008 Jul; 123(1):1-7. PubMed ID: 18425819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormalities of molecular biology in premalignant lung lesions].
    Shao SJ; Wang Y; Yang PM
    Ai Zheng; 2004 Jan; 23(1):99-103. PubMed ID: 14720385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.